Abeer Moanna MD
Overview
Abeer Moanna joined the division of Infectious Diseases at Emory as a junior faculty in 2005 at the Atlanta VA Medical Center. Abeer received her medical degree from the American University of Beirut in 1999. She completed her internship and residency at Emory University in 2002 and was a chief resident in Internal Medicine at GMH (2002-2003). Afterwards, she joined the Emory ID fellowship for 3 years.
Abeer is the Chief of Infectious Diseases at the Atlanta VA Medical Center. Between 2010 -2016, Abeer was the Infectious Diseases (ID) clinic director at the Atlanta VA, currently serving around 1700 veterans with HIV infection. The Atlanta IDC provides HIV care in addition to comprehensive primary care to enrolled veterans. In 2013, she became the ID Associate Clinical Chief of Service at the VA hospital. She took the role of Acting Chief of ID in July 2015 and became the Chief of ID service at the Atlanta VA in May 2016 where she oversees the inpatient and outpatient clinic operations in addition to supervising the ID staff, mid-level providers, and a large number of WOC providers.
Academic Appointment
- Distinguished Physician, Emory University School of Medicine
- Associate Professor of Medicine, Emory University School of Medicine
- Chief of Infectious Diseases, Atlanta VA Medical Center
Education
Degrees
- MD from American University of Beirut
- BS from American University of Beirut
Research
Focus
- HIV immunopathogenesis and HIV clinical/translational research. During fellowship, my research in the laboratory of Guido Silvestri M.D. at the National Primates Center at Emory University (Yerkes) involved looking at the role of immune activation in HIV pathogenesis through studying the role of IL-2 administration to HIV infected subjects and its effect on markers of immune activation. Currently, I am working on a study of Inflammatory markers and biomarkers of endothelial cell activation in HIV-infected subjects at the Atlanta VAMC.
Publications
-
Immunomodulators for immunocompromised patients hospitalized for COVID-19: a meta-analysis of randomized controlled trials.
EClinicalMedicine Volume: 69 Page(s): 102472
03/01/2024 Authors: Siempos II; Kalil AC; Belhadi D; Veiga VC; Cavalcanti AB; Branch-Elliman W; Papoutsi E; Gkirgkiris K; Xixi NA; Kotanidou A -
Design and methods of a randomized trial testing "Advancing care for COPD in people living with HIV by implementing evidence-based management through proactive E-consults (ACHIEVE)".
Contemp Clin Trials Volume: 132 Page(s): 107303
09/01/2023 Authors: Ives J; Bagchi S; Soo S; Barrow C; Akgn KM; Erlandson KM; Goetz M; Griffith M; Gross R; Hulgan T -
The association between comorbidities and coronavirus disease 2019 hospitalization among people with HIV differs by age.
AIDS Volume: 37 Page(s): 71 - 81
01/01/2023 Authors: Moran CA; Oliver NT; Szabo B; Collins LF; Nguyen MLT; Shah NS; Moanna A; Colasanti JA; Cantos VD; Armstrong WS -
Trends in Cause-Specific Mortality Among Veterans With HIV: A 35-Year (1982-2016) Analysis of the HIV Atlanta VA Cohort Study.
J Acquir Immune Defic Syndr Volume: 92 Page(s): 17 - 26
01/01/2023 Authors: Vyas KJ; Marconi VC; Moanna A; Rimland D; Guest JL -
Baricitinib versus dexamethasone for adults hospitalised with COVID-19 (ACTT-4): a randomised, double-blind, double placebo-controlled trial.
Lancet Respir Med Volume: 10 Page(s): 888 - 899
09/01/2022 Authors: Wolfe CR; Tomashek KM; Patterson TF; Gomez CA; Marconi VC; Jain MK; Yang OO; Paules CI; Palacios GMR; Grossberg R -
Clinical characteristics and social determinants of health associated with 30-day hospital readmissions of patients with COVID-19.
J Investig Med Volume: 70 Page(s): 1406 - 1415
08/01/2022 Authors: Wiley Z; Kulshreshtha A; Li D; Kubes J; Kandiah S; Leung S; Kobaidze K; Shin SR; Moanna A; Perkins J -
Rapid Antiretroviral Therapy Program: Development and Evaluation at a Veterans Affairs Medical Center in the Southern United States.
AIDS Patient Care STDS Volume: 36 Page(s): 219 - 225
06/01/2022 Authors: O'Shea JG; Gallini JW; Cui X; Moanna A; Marconi VC -
Lessons from a tuberculosis contact investigation at a federal healthcare facility during the coronavirus disease 2019 (COVID-19) pandemic.
Antimicrob Steward Healthc Epidemiol Volume: 2 Page(s): e145
01/01/2022 Authors: Powell KM; Crosby KY; Moanna AA; Greene A; Epstein L -
Efficacy of interferon beta-1a plus remdesivir compared with remdesivir alone in hospitalised adults with COVID-19: a double-bind, randomised, placebo-controlled, phase 3 trial.
Lancet Respir Med Volume: 9 Page(s): 1365 - 1376
12/01/2021 Authors: Kalil AC; Mehta AK; Patterson TF; Erdmann N; Gomez CA; Jain MK; Wolfe CR; Ruiz-Palacios GM; Kline S; Regalado Pineda J -
Safety and Efficacy of Single-Dose Ad26.COV2.S Vaccine against Covid-19.
N Engl J Med Volume: 384 Page(s): 2187 - 2201
06/10/2021 Authors: Sadoff J; Gray G; Vandebosch A; Crdenas V; Shukarev G; Grinsztejn B; Goepfert PA; Truyers C; Fennema H; Spiessens B